The isomorphous structures of prethrombin2, hirugen–, and PPACK–thrombin: Changes accompanying activation and exosite binding to thrombin
J. Vijayalakshmi
Department of Chemistry, Michigan State University, East Lansing, Michigan 48824–1322
Search for more papers by this authorK.P. Padmanabhan
Department of Chemistry, Michigan State University, East Lansing, Michigan 48824–1322
Search for more papers by this authorCorresponding Author
A. Tulinsky
Department of Chemistry, Michigan State University, East Lansing, Michigan 48824–1322
Department of Chemistry, Michigan State University, East Lansing, Michigan 48824–1322Search for more papers by this authorK.G. Mann
Department of Biochemistry, College of Medicine, University of Vermont, Burlington, Vermont 05405–0068
Search for more papers by this authorJ. Vijayalakshmi
Department of Chemistry, Michigan State University, East Lansing, Michigan 48824–1322
Search for more papers by this authorK.P. Padmanabhan
Department of Chemistry, Michigan State University, East Lansing, Michigan 48824–1322
Search for more papers by this authorCorresponding Author
A. Tulinsky
Department of Chemistry, Michigan State University, East Lansing, Michigan 48824–1322
Department of Chemistry, Michigan State University, East Lansing, Michigan 48824–1322Search for more papers by this authorK.G. Mann
Department of Biochemistry, College of Medicine, University of Vermont, Burlington, Vermont 05405–0068
Search for more papers by this authorAbstract
The X-ray crystal structure of prethrombin2 (pre2), the immediate inactive precursor of α-thrombin, has been determined at 2.0 Å resolution complexed with hirugen. The structure has been refined to a final R-value of 0.169 using 14,211 observed reflections in the resolution range 8.0–2.0 Å. A total of 202 water molecules have also been located in the structure. Comparison with the hirugen–thrombin complex showed that, apart from the flexible beginning and terminal regions of the molecule, there are 4 polypeptide segments in pre2 differing in conformation from the active enzyme (Pro 186–Asp 194, Gly 216–Gly 223, Gly 142–Pro 152, and the Arg 15–Ile 16 cleavage region). The formation of the Ile 16–Asp 194 ion pair and the specificity pocket are characteristic of serine protease activation with the conformation of the catalytic triad being conserved.
With the determination of isomorphous structures of hirugen–thrombin and d-Phe-Pro-Arg chloromethyl ketone (PPACK)–thrombin, the changes that occur in the active site that affect the kinetics of chromogenic substrate hydrolysis on binding to the fibrinogen recognition exosite have been determined. The backbone of the Ala 190–Gly 197 segment in the active site has an average RMS difference of 0.55 Å between the 2 structures (about 3.7σ compared to the bulk structure). This segment has 2 type II β-bends, the first bend showing the largest shift due to hirugen binding. Another important feature was the 2 different conformations of the side chain of Glu 192. The side chain extends to solvent in hirugen–thrombin, which is compatible with the binding of substrates having an acidic residue in the P3 position (protein-C, thrombin platelet receptor). In PPACK–thrombin, the side chain of Asp 189 and the segment Arg 221A–Gly 223 move to provide space for the inhibitor, whereas in hirugenthrombin, the Ala 190–Gly 197 movement expands the active site region. Although 8 water molecules are expelled from the active site with PPACK binding, the inhibitor complex is resolvated with 5 other water molecules.
References
- Arni RK, Padmanabhan K, Padmanabhan KP, Wu TP, Tulinsky A. 1993. Structures of the non-covalent complexes of human and bovine prothrombin fragment 2 with human PPACK–thrombin. Biochemistry 32: 4727–4737.
- Bode W, Huber R. 1978. Crystal structure analysis and refinement of two variants of trigonal trypsinogen. FEBS Lett 90: 265–268.
- Bode W, Meyer I, Baumann U, Huber R, Stone SR, Hofsteenge J. 1989. The refined 1.9 Å crystal structure of human α-thrombin: Interaction with d-Phe-Pro-Arg chloromethyl ketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 8: 3467–3475.
- Bode W, Turk D, Karshikov A. 1992. The refined 1.9 Å X-ray crystal structure of d-Phe-Pro-Arg chloromethyl ketone-inhibited human α-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active site geometry and structure function relationships. Protein Sci 1: 426–471.
- Brünger AT. 1990. X-PLOR manual, version 2.1. New Haven, Connecticut: Yale University.
- Chang JY. 1986. The structures and proteolytic specificities of autolysed human thrombin. Biochem J 240: 797–802.
- Chirgadze NY, Clawson DK, Gesellchen PD, Hermann RB, Kaiser RE Jr, Olkowski JL, Sall DJ, Schevitz RW, Smith GF, Shuman RT, Wery JP, Jones ND. 1992. The X-ray structure at 2.2 Å resolution of a ternary complex containing human alpha-thrombin, a hirudin peptide (54–65) and an active site inhibitor. ACA Annual Meeting, Pittsburgh, Pennsylvania, August 9–14, 1992. Abstr PB33.
- Church FC, Pratt CW, Noyes CM, Kalayanamit T, Sherill GB, Tobin RB, Meade JB. 1989. Structural and functional properties of human α-thrombin, phosphopyridoxylated α-thrombin and γT-thrombin: Identification of lysyl residues in α-thrombin that are critical for heparin and fibrin(ogen) interactions. J Biol Chem 264: 18419–18425.
- Crawford JL, Lipscomb WN, Schellman CG. 1973. The reverse turn as a polypeptide conformation in globular proteins. Proc Natl Acad Sci USA 70: 538–542.
- Dennis S, Wallace A, Hofsteenge J, Stone SR. 1990. Use of fragments of hirudin to investigate the thrombin–hirudin interaction. Eur J Biochem 188: 61–66.
- Downing MR, Butkowski RJ, Clark MM, Mann KG. 1975. Human prothrombin activation. J Biol Chem 250: 8897–8906.
- Erhlich HJ, Grinnell BW, Jaskunas SR, Esmon CT, Yan SB, Bang NU. 1990. Recombinant human protein C derivatives: Altered response to calcium resulting in enhanced activation by thrombin. EMBO J 9: 2367–2373.
- Esmon CT. 1989. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264: 4743–4746.
- Fenton JW II. 1981. Thrombin specificity. Ann NY Acad Sci 370: 468–495.
- Fenton JW II. 1986. Thrombin. Ann NY Acad Sci 485: 5–15.
- Fenton JW II, Fasco MJ, Stackrow AB, Aronson DL, Young AM, Finlayson JS. 1977. Human thrombins: Production evaluation, and properties of α-thrombin. J Biol Chem 252: 3587–3598.
- Freer ST, Kraut J, Robertus JD, Wright HT, Xuong NgH. 1970. Chymotrypsinogen: 2.5 Å crystal structure, comparison with α-chymotrypsin, and implications for zymogen activation. Biochemistry 9: 1997–2009.
- Hassan MI. 1985. Selected proteolysis of prothrombin, factor V, factor VIII, and factor X with the venom proteases of Naja nigricollis and Cerastes cerastes. Cairo, Egypt: Ain Shams University.
- Henderson R. 1970. Structure of crystalline α-chymotrypsin. IV. The structure of indoleacryloyl-α-chymotrypsin and its relevance to the hydrolytic mechanism of the enzyme. J Mol Biol 54: 341–354.
- Higashi T. 1990. Auto indexing of oscillation images. J Appl Crystallogr 23: 253–257.
- Hortin GL, Trimpe BL. 1991. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates. J Biol Chem 266: 6866–6871.
- Hubbard SJ, Campbell SF, Thornton JM. 1991. Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J Mol Biol 220: 507–530.
- Hubbard SJ, Eisenmenger F, Thornton JM. 1994. Modeling studies of the changes in conformation required for cleavage of limited proteolytic sites. Protein Sci 3: 757–768.
- Huber R, Bode W. 1978. Structural basis of the activation and action of trypsin. Acc Chem Res 11: 114–122.
- Huber R, Kukla D, Bode W, Schwager P, Bartels K, Deisenhofer J, Steigemann W. 1974. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 Å resolution. J Mol Biol 89: 73–101.
- Jones TA. 1982. Frodo: A graphics fitting program for macromolecules. In: D Sayre, ed. Computational crystallography. Oxford, UK: Clarendon. pp 303–317.
- Karshikov A, Bode W, Tulinsky A, Stone SR. 1992. Electrostatic interactions in the association of proteins: An analysis of the thrombin–hirudin complex. Protein Sci 1: 727–735.
- Konno S, Fenton JW II, Villanueva GB. 1988. Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin. Arch Biochem Biophys 267: 158–166.
- Krishnaswany S, Church WR, Nesheim ME, Mann KG. 1987. Activation of human prothrombin by human prothrombinase: Influence of factor Va on the reaction mechanism. J Biol Chem 262: 3291–3299.
- Krstenansky JL, Broersman RJ, Owen TJ, Payne MH, Mao SJT. 1990. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin. Thromb Haemostasis 63: 208–214.
- Le Bonniec BF, Esmon CT. 1991. Glu-192 Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc Natl Acad Sci USA 88: 7371–7375.
- Liu LW, Vu TKH, Esmon CT, Coughlin SR. 1991a. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem 266: 16977–16980.
- Liu LW, Ye J, Johnson AE, Esmon CT. 1991b. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen binding site. J Biol Chem 266: 23632–23636.
- Luzatti V. 1952. Traitement statistique des erreurs dans la determination des structures cristallines. Acta Crystallogr 5: 802–810.
- Madison EI, Kobe A, Gething MJ, Sambrook JF, Goldsmith EJ. 1993. Converting tissue plasminogen activator to a zymogen: A regulatory triad of Asp-His-Ser. Science 262: 419–421.
- Mann KG. 1976. Prothrombin. In: L Lorand, ed. Methods in enzymology, proteolytic enzymes, XLV, part B. New York: Academic Press, pp 123–156.
- Mann KG. 1987. The assembly of blood clotting complexes on membranes. Trends Biochem Sci 12: 229–233.
- Mao SJT, Yates MT, Owen TJ, Krstenansky JL. 1988. Interaction of hirudin with thrombin: Identification of a minimal binding domain of hirudin that inhibits clotting activity. Biochemistry 27: 8170–8173.
- Maryanoff BE, Qiu X, Padmanabhan KP, Tulinsky A, Almond HR, Andrade-Gordon P, Greco MN, Kauffman JA, Nicolaou KG, Liu A, Brungs PH, Fusetani N. 1993. Molecular basis for the inhibition of human α-thrombin by the macrocyclic peptide cyclotheonamideA. Proc Natl Acad Sci USA 90: 8048–8052.
- Mathews II, Padmanabhan KP, Ganesh V, Tulinsky A, Ishii M, Chen J, Turck CW, Coughlin SR, Fenton JW II. 1994. Crystallographic structures of thrombin complexed with thrombin receptor peptides: Existence of expected and novel binding modes. Biochemistry 33: 3266–3279.
- Mathews II, Tulinsky A. 1995. Active site mimetic inhibition of thrombin. Acta Crystallogr D. Forthcoming.
- Naski MC, Fenton JW II, Maraganore JM, Olson ST, Shafer JA. 1990. The COOH-terminal domain of hirudin: An exosite-directed competitive inhibitor on the action of α-thrombin on fibrinogen. J Biol Chem 265: 13484–13489.
- Ni F, Ning Z, Jackson CM, Fenton JW II. 1993. Thrombin exosite for fibrinogen recognition is partially accessible in prothrombin. J Biol Chem 268: 16899–16902.
- Ni F, Ripoll DR, Martin PD, Edwards BFP. 1992. Solution structure of a platelet receptor peptide bound to bovine α-thrombin. Biochemistry 31: 11551–11557.
- Padmanabhan K, Padmanabhan KP, Tulinsky A, Park CH, Bode W, Huber R, Blankenship DT, Cardin AD, Kisiel W. 1993. Structure of human des (1–45)-Factor Xa at 2.2 Å resolution. J Mol Biol 232: 947–966.
- Parry MAA, Stone SR, Hofsteenge J, Jackman MP. 1993. Evidence for common structural changes in thrombin induced by active-site or exosite binding. Biochem J 290: 665–670.
- Priestle JP. 1988. RIBBON: A stereo cartoon drawing program for proteins. J Appl Crystallogr 21: 572–576.
- Priestle JP, Rahuel J, Rink H, Tones M, Grutter MG. 1993. Changes in interaction in complexes of hirudin derivatives and human α-thrombin due to different crystal forms. Protein Sci 2: 1630–1642.
- Qiu X, Padmanabhan KP, Carperos VE, Tulinsky A, Kline T, Maraganore JM, Fenton JW II. 1992. Structure of the hirulog 3–thrombin complex and nature of the S' subsites of substrates and inhibitors. Biochemistry 31: 11689–11697.
- Qiu X, Yin M, Padmanabhan KP, Krstenansky JL, Tulinsky A. 1993. Structures of thrombin complexes with a designed and natural exosite peptide inhibitor. J Biol Chem 268: 20318–20326.
- Robertus JD, Kraut J, Alden RA, Birktoft JJ. 1972. Subtilisin: A stereochemical mechanism involving transition-state stabilization. Biochemistry 11: 4293–4303.
- Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, Fenton JW II. 1990. The structure of a complex of recombinant hirudin and human α-thrombin. Science 249: 277–280.
- Rydel TJ, Tulinsky A, Bode W, Huber R. 1991. Refined structure of the hirudin-thrombin complex. J Mol Biol 221: 583–601.
- Rydel TJ, Yin M, Padmanabhan KP, Blankenship DT, Cardin AD, Correa PM, Fenton JW II, Tulinsky A. 1994. Crystallographic structure of human γ-thrombin. J Biol Chem 269: 22000–22006.
- Schechter I, Berger A. 1967. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27: 157–162.
- Singh TP, Bode W, Huber R. 1980. Low temperature protein crystallography. Effect on flexibility, temperature factor, mosaic spread, extinction and diffuse scattering in two examples: Bovine trypsinogen and Fc fragment. Acta Crystallogr B 36: 621–627.
- Skrzypczak-Jankun E, Carperos VE, Ravichandran KG, Tulinsky A, Westbrook M, Maraganore JM. 1991. Structure of the hirugen and hirulog 1 complexes of α-thrombin. J Mol Biol 221: 1379–1393.
- Skrzypczak-Jankun E, Rydel TJ, Tulinsky A, Fenton JW II, Mann KG. 1989. Human d-phe-pro-arg-CH2-α-thrombin crystallization and diffraction data. J Mol Biol 206: 755–757.
- Stevens WK, Nesheim ME. 1993. Structural changes in the protease domain of prothrombin upon activation as assessed by N-bromosuccinimide modification of tryptophan residues in prethrombin-2 and thrombin. Biochemistry 32: 2787–2794.
- Thaller C, Eichele G, Weaver LH, Wilson E, Karlsson R, Jansonius JN. 1985. Seed enlargement and repeated seeding. Methods Enzymol 114: 132–135.
- Venkatachalam CM. 1968. Stereochemical criteria for polypeptides and proteins. I. Conformation of a system of three linked peptide units. Biopolymers 6: 1425–1436.
- Walter J, Steigemann W, Singh TP. 1982. On the disordered activation domain in trypsinogen: Chemical labelling and low temperature crystallography. Acta Crystallogr B 38: 1462–1472.
- Wang D, Bode W, Huber R. 1985. Bovine chymotrypsinogen A: X-ray crystal structure analysis and refinement of a new crystal form at 1.8 Å resolution. J Mol Biol 185: 595–624.
- Wright HT. 1973. Activation of chymotrypsinogen-A: A hypothesis based upon comparison of the crystal structures of chymotrypsinogen-A and α-chymotrypsin. J Mol Biol 79: 13–23.
- Wu Q, Picard V, Aiach M, Sadler JE. 1994. Activator-induced exposure of the thrombin anion-binding exosite. J Biol Chem 269: 3725–3730.
- Zdanov A, Wu S, DiMaio J, Konishi Y, Li Y, Wu X, Edwards BFP, Martin PD, Cygler M. 1993. Crystal structure of the complex of human α-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6. Proteins Struct Funct Genet 17: 252–265.